Stock Earnings

Question 1

Quels sont les états financiers clés de Vir Biotechnology Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Vir Biotechnology Inc a un total d'actifs de $1,398, un bénéfice net loss de $-521

Question 2

Quels sont les ratios financiers clés pour VIR ?

Accepted Answer

Le ratio de liquidité de Vir Biotechnology Inc est 5.63, la marge nette est -704.05, les ventes par action sont de $0.54.

Question 3

Comment les revenus de Vir Biotechnology Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Vir Biotechnology Inc largest revenue segment is Antibody-based Therapies, at a revenue of 74,205,000 in the most earnings release.For geography, United States is the primary market for Vir Biotechnology Inc, at a revenue of 74,205,000.

Question 4

Vir Biotechnology Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Vir Biotechnology Inc a un bénéfice net loss de $-521

Question 5

Vir Biotechnology Inc a-t-elle des passifs ?

Accepted Answer

yes, Vir Biotechnology Inc a un passif de 248

Question 6

Combien d'actions en circulation Vir Biotechnology Inc a-t-elle ?

Accepted Answer

Vir Biotechnology Inc a un total d'actions en circulation de 136.95

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	19	74	86	1,615	1,095	76
Revenue Growth (YoY)	-76%	-14%	-95%	47%	1,341%	850%
Cost of Revenue	0	0	2	146	65	--
Gross Profit	18	73	83	1,469	1,029	--
Selling, General & Admin	98	119	178	161	160	70
Research & Development	517	506	589	474	447	301
Operating Expenses	616	625	767	636	608	373
Other Non Operating Income (Expenses)	-1	-2	-8	4	-9	-4
Pretax Income	-549	-523	-628	754	549	-298
Income Tax Expense	0	-1	-13	238	21	0
Net Income	-550	-521	-615	515	528	-298
Net Income Growth	14%	-15%	-219%	-2%	-277%	71%
Shares Outstanding (Diluted)	138.44	136.24	134.13	134.8	133.4	119.2
Shares Change (YoY)	2%	2%	-1%	1%	12%	293%
EPS (Diluted)	-3.97	-3.83	-4.58	3.83	3.96	-2.51
EPS Growth	12%	-16%	-220%	-3%	-258%	-56%
Free Cash Flow	-466	-453	-800	1,595	-69	-197
Free Cash Flow Per Share	-3.36	-3.32	-5.96	11.83	-0.51	-1.65
Gross Margin	94.73%	98.64%	96.51%	90.95%	93.97%	--
Operating Margin	-3,142.1%	-745.94%	-795.34%	51.57%	38.35%	-390.78%
Profit Margin	-2,894.73%	-704.05%	-715.11%	31.88%	48.21%	-392.1%
Free Cash Flow Margin	-2,452.63%	-612.16%	-930.23%	98.76%	-6.3%	-259.21%
EBITDA	-586	-538	-665	839	425	-292
EBITDA Margin	-3,084.21%	-727.02%	-773.25%	51.95%	38.81%	-384.21%
D&A For EBITDA	11	14	19	6	5	5
EBIT	-597	-552	-684	833	420	-297
EBIT Margin	-3,142.1%	-745.94%	-795.34%	51.57%	38.35%	-390.78%
Effective Tax Rate	0%	0.19%	2.07%	31.56%	3.82%	0%

Vir Biotechnology Inc (VIR) Price

VIR Stock Price Chart

VIR Income

Follow-Up Questions